CLINICAL_TRIALS
trial_result
· 2014-10-31
Clinical Trial Update: Lovastatin in Treating Patients At High Risk of Melanoma [Phase 2]
Summary
Phase 2 clinical trial evaluating lovastatin in people at high risk of developing melanoma; the study is completed and results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Precancerous Condition, Stage 0 Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-10-31